However, while the combination of MRI techniques to quantify the effects of GLP‐1 has shown promise in reducing appetite, curbing unintentional intake and controlling long‐term body weight [22], limited studies have explored the relationship between changes in liver fat content and the degree of remission of diabetes mellitus and comorbidities. The gene discussed is GCG; the disease is diabetes mellitus.